Literature DB >> 15909312

Post-thymic in vivo proliferation of naive CD4+ T cells constrains the TCR repertoire in healthy human adults.

Siegfried Kohler1, Ulf Wagner, Matthias Pierer, Sonja Kimmig, Birgit Oppmann, Beate Möwes, Kerstin Jülke, Chiara Romagnani, Andreas Thiel.   

Abstract

In spite of thymic involution early in life, the numbers of naive CD4(+) T cells only slowly decline in ageing humans implying peripheral post-thymic naive CD4(+) T cell expansion. This proliferation may compensate for continuous activation and death of naive CD4(+) T cells but may also have negative consequences for protective immunity. Here we show that naive CD4(+) T cells that have proliferated in the periphery are characterized by a highly restricted oligoclonal TCR repertoire. Additionally these cells, which constitute the majority of naive CD4(+) T cells in the elderly, display signatures of recent TCR engagement. Our results demonstrate for the first time that peripheral post-thymic proliferation of naive CD4(+) T cells in healthy human individuals causes a significant contraction of the peripheral TCR repertoire. This age-dependent deterioration of CD4(+) T cell immunity could entail ageing-associated autoimmunity, increased susceptibility to infection or cancer and decreased efficiency of vaccination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15909312     DOI: 10.1002/eji.200526181

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  59 in total

Review 1.  Reversing T cell immunosenescence: why, who, and how.

Authors:  Pierre Olivier Lang; Sheila Govind; Richard Aspinall
Journal:  Age (Dordr)       Date:  2012-02-26

Review 2.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

Review 3.  A challenge for the future: aging and HIV infection.

Authors:  Tammy M Rickabaugh; Beth D Jamieson
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

4.  Homeostasis of the naive CD4+ T cell compartment during aging.

Authors:  Ryan D Kilpatrick; Tammy Rickabaugh; Lance E Hultin; Patricia Hultin; Mary Ann Hausner; Roger Detels; John Phair; Beth D Jamieson
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

5.  CD31, a Valuable Marker to Identify Early and Late Stages of T Cell Differentiation in the Human Thymus.

Authors:  Marc Douaisi; Rachel S Resop; Maho Nagasawa; Joshua Craft; Beth D Jamieson; Bianca Blom; Christel H Uittenbogaart
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

6.  Neonatal thymectomy reveals differentiation and plasticity within human naive T cells.

Authors:  Theo van den Broek; Eveline M Delemarre; Willemijn J M Janssen; Rutger A J Nievelstein; Jasper C Broen; Kiki Tesselaar; Jose A M Borghans; Edward E S Nieuwenhuis; Berent J Prakken; Michal Mokry; Nicolaas J G Jansen; Femke van Wijk
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

Review 7.  Gain and loss of T cell subsets in old age--age-related reshaping of the T cell repertoire.

Authors:  Christoph R Arnold; Juliane Wolf; Stefan Brunner; Dietmar Herndler-Brandstetter; Beatrix Grubeck-Loebenstein
Journal:  J Clin Immunol       Date:  2011-01-18       Impact factor: 8.317

8.  The contribution of the thymus to the recovery of peripheral naive T-cell numbers during antiretroviral treatment for HIV infection.

Authors:  Ruy M Ribeiro; Rob J de Boer
Journal:  J Acquir Immune Defic Syndr       Date:  2008-09-01       Impact factor: 3.731

9.  Age-related differences in integrin expression in peripheral blood lymphocytes.

Authors:  Christine V Crooks; Martin L Cross; Clare R Wall
Journal:  Immun Ageing       Date:  2010-04-26       Impact factor: 6.400

10.  Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function.

Authors:  Christopher J Haines; Thierry D Giffon; Li-Sheng Lu; Xiaowei Lu; Marc Tessier-Lavigne; Douglas T Ross; David B Lewis
Journal:  J Exp Med       Date:  2009-01-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.